
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Wnt-5b CRISPR/Cas9 KO Plasmid (m) | sc-423719 | 20 µg | $397.00 |
Mouse Wnt5b encodes the secreted glycoprotein Wnt-5b, a non-canonical Wnt ligand that regulates cell polarity, directional migration, and cytoskeletal remodeling during development and tissue homeostasis. Wnt-5b preferentially signals through β-catenin–independent pathways such as planar cell polarity and Wnt/Ca2+ signaling, engaging receptors including Frizzled and co-receptors such as ROR family tyrosine kinases to tune downstream JNK, PKC, and small GTPase activity. These pathways influence morphogenesis, neuronal patterning, and stromal–epithelial communication, and dysregulated WNT5B expression has been linked to altered differentiation programs and invasive cell behaviors in disease-related contexts. As a pathway node that intersects with inflammatory and extracellular matrix signaling, Wnt-5b is frequently examined in models of development, metabolism, and tumor microenvironment biology.
Wnt-5b CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Wnt5b gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Wnt5b together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Wnt5b open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Wnt-5b protein expression.
This CRISPR knockout system enables efficient generation of Wnt5b-deficient cell models for investigation of Wnt-5b signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.